[1] Oyaska J, Jarvinen H, Kujari H, et al. Follow-up patients operated on for colorectal carcinoma[J]. Am J Sur, 1990, 159: 539-96. [2] Kune GA, Kune S, Fied B, et al. Survival in patients with large bowel cancer[J]. Dis Colon Rectum, 1990, 33938-946. [3] Soreide O, Norstein. Local recurrence after operative treatment of rectal carcinoma: A strategy for chance [J]. J Am Coil Surg, 1997,184: 84-92. [4] Du WB, Chia KS, Sankaranarayanan R. Population-based survival analysis of colorectal cancer patients in Singapore, 1968-1992 [J].Int J Cancer, 2002, 99(3): 460-5. [5] Vander Pompe G, Antoni MH, Visser A, et al. Effect of mild acute stress on immune cell distribution and natural killer cell activity in breast cancer patients[J]. Biol Psychol, 1998, 48(1): 21-5. [6] Yoon SJ, Heo DS, Kang SH, et al. Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression [J]. Anticancer Res, 1998, 18 (3A):1591-6. [7] Carson WE, Parihar R, Lindemann MJ, et al. Interleukin-2 enhances the natural cell response to Herceptin-coated Her2/neu-positive breast cancer cells[J]. Eur J Immunol, 2001, 31(10): 3016-25. [8] Ishigami S, Natsugoe S, Tokuda K, et al. Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer[J]. Cancer Lett, 2000, 159(1): 103-8. [9] Cooley S, Burns LJ, Repka T, et al. Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA -3 and HER2/neu[J]. Exp Hematol. 1999, 27(10): 1533-41. [10] Dunn J, Lynch B, Aitken J, et al. Quality of life and colorectal cancer: a review[J]. Aust J Health, 2003, 27(1): 41-53. |